167 related articles for article (PubMed ID: 5121129)
1. L-DOPA therapy in drug-induced parkinsonism evaluated by the method measuring the facial expression.
Kimura N; Tsukue I
Hiroshima J Med Sci; 1971 Mar; 20(1):55-63. PubMed ID: 5121129
[No Abstract] [Full Text] [Related]
2. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
[No Abstract] [Full Text] [Related]
3. [Treatment of parkinsonism with the drug L-DOPA].
Stoliarova LG; Kistenev BA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
[No Abstract] [Full Text] [Related]
4. Effects of L-DOPA on pharmacological parkinsonism.
Bruno A; Bruno SC
Acta Psychiatr Scand; 1966; 42(3):264-71. PubMed ID: 5335155
[No Abstract] [Full Text] [Related]
5. [Therapy of parkinsonian syndromes with L-dopa. Results and prospects].
Fazio C
Sist Nerv; 1970; 22(2):61-6. PubMed ID: 5504558
[No Abstract] [Full Text] [Related]
6. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
Gerstenbrand F; Grünberger J; Schubert H
Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
[No Abstract] [Full Text] [Related]
7. [Clinical experience with L-DOPA in the treatment of parkinsonism].
Chiba T
No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833
[No Abstract] [Full Text] [Related]
8. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
Sugita K; Mutsuga N; Takaoka Y; Takeda A
No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927
[No Abstract] [Full Text] [Related]
9. Quantitative measurements of L-dopa therapy in Parkinson's disease.
Webster DD
Trans Am Neurol Assoc; 1969; 94():348-50. PubMed ID: 5374483
[No Abstract] [Full Text] [Related]
10. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
Hippius H; Logemann G
Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051
[No Abstract] [Full Text] [Related]
11. [Pathogenesis and treatment of manganese induced Parkinsonism].
Ryzhkova MN; Tarasova LA
Gig Tr Prof Zabol; 1975 Nov; (11):31-4. PubMed ID: 1205189
[No Abstract] [Full Text] [Related]
12. [Case of parkinsonism with remission of symptoms by the administration of L-DOPA].
Tsuyuzaki K; Onai M; Uehara A; Shimojo H; Sudo H
Naika; 1970 Nov; 26(5):986-8. PubMed ID: 5478157
[No Abstract] [Full Text] [Related]
13. [Habituation of trigemino-facial reflexes in parkinsonism treated with L-DOPA].
Messina C
Riv Neurol; 1970; 40(5):327-36. PubMed ID: 5507461
[No Abstract] [Full Text] [Related]
14. Treatment of parkinsonism with L-dopa (study of 105 patients).
Klawans HL; Garvin JS
Dis Nerv Syst; 1969 Nov; 30(11):737-46. PubMed ID: 5359046
[No Abstract] [Full Text] [Related]
15. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
Mones RJ; Elizan TS
J Mt Sinai Hosp N Y; 1969; 36(6):503-15. PubMed ID: 5261089
[No Abstract] [Full Text] [Related]
16. [Results of treatment of Parkinsonism with L-dopa].
De Divitiis E; D'Andrea F; Signorelli CD
Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
[No Abstract] [Full Text] [Related]
17. [L-DOPA therapy of parkinsonism].
Refsum S
Nord Med; 1969 May; 81(18):570-1. PubMed ID: 5768311
[No Abstract] [Full Text] [Related]
18. L-dopa and parkinsonism.
Okihiro MM
Hawaii Med J; 1971; 30(5):390-2. PubMed ID: 5160226
[No Abstract] [Full Text] [Related]
19. L-dopa and parkinsonism.
Stuart WH
J Med Assoc Ga; 1970 Aug; 59(8):331-2. PubMed ID: 5451035
[No Abstract] [Full Text] [Related]
20. [Drug-induced Parkinson's syndrome].
Degkwitz R
Dtsch Med Wochenschr; 1972 Jun; 97(22):882. PubMed ID: 5032182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
